Tredje Ap Fonden Amgen Inc Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

A detailed history of Tredje Ap Fonden transactions in Amgen Inc stock. As of the latest transaction made, Tredje Ap Fonden holds 76,542 shares of AMGN stock, worth $20.2 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

76,542

Previous 109,542 30.13%

Holding current value

$20.2 Million

Previous $34.2 Million 27.94%

% of portfolio

0.23%

Previous 0.33%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $10.2 Million - $11.1 Million	-33,000 Reduced 30.13%	76,542 $24.7 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $3.42 Million - $4.15 Million	-13,010 Reduced 10.62%	109,542 $34.2 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $1.61 Million - $1.95 Million	6,000 Added 5.15%	122,552 $34.8 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $2.99 Million - $3.37 Million	11,690 Added 11.15%	116,552 $33.6 Million
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $178,199 - $221,239	815 Added 0.78%	104,862 $28.2 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $3.26 Million - $3.85 Million	15,194 Added 17.1%	104,047 $23.1 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $857,324 - $1.04 Million	3,797 Added 4.46%	88,853 $21.5 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $10.9 Million - $13.8 Million	-47,523 Reduced 35.85%	85,056 $22.3 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $15.4 Million - $17.3 Million	68,444 Added 106.72%	132,579 $29.9 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $370,911 - $424,474	-1,865 Reduced 2.83%	64,135 $14.4 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $4.65 Million - $5.71 Million	-23,529 Reduced 26.28%	66,000 $15.6 Million
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $3.93 Million - $5.21 Million	21,570 Added 31.74%	89,529 $16.2 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $1.76 Million - $2.26 Million	-9,292 Reduced 12.03%	67,959 $16.4 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $3.76 Million - $4.5 Million	-21,574 Reduced 21.83%	77,251 $14.9 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $2.05 Million - $2.41 Million	12,321 Added 14.24%	98,825 $18.2 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $2.27 Million - $2.56 Million	12,551 Added 16.97%	86,504 $16.4 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $5.43 Million - $6.33 Million	-30,417 Reduced 29.14%	73,953 $14.4 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $1.88 Million - $2.11 Million	-11,324 Reduced 9.79%	104,370 $19.3 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $209,754 - $245,124	-1,238 Reduced 1.06%	115,694 $19.7 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $162,038 - $181,046	960 Added 0.83%	116,932 $20.3 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $19.4 Million - $22.2 Million	115,972	115,972 $21.6 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account